An Act relative to pharmaceutical access, costs and transparency
- Introduced Oct 30, 2023
- In committee Oct 30, 2023
- Died
- Passed the House
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
Senate, October 30, 2023 -- The committee on Health Care Financing, to whom was referred the petitions (accompanied by bill, Senate, No. 732) of John J. Cronin for legislation to promote comprehensive transparency in the pharmaceutical industry; (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for…
Read the full title (389 words)
Senate, October 30, 2023 -- The committee on Health Care Financing, to whom was referred the petitions (accompanied by bill, Senate, No. 732) of John J. Cronin for legislation to promote comprehensive transparency in the pharmaceutical industry; (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency; (accompanied by bill, Senate, No. 767) of Jason M. Lewis for legislation to define modest meals and refreshments in prescriber education settings; (accompanied by bill, Senate, No. 778) of Paul W. Mark for legislation to bring down the cost of prescription drugs; (accompanied by bill, Senate, No. 783) of Mark C. Montigny and Michael J. Barrett for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices; (accompanied by bill, Senate, No. 784) of Mark C. Montigny for legislation relative to coverage for chronic illness; (accompanied by bill, Senate, No. 797) of Jacob R. Oliveira for legislation to bring down the cost of prescription drugs; (accompanied by bill, House, No. 619) of Nicholas A. Boldyga relative to establishing a prescription drug rebate program for seniors; (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry; (accompanied by bill, House, No. 1201) of Kate Hogan relative to the pricing of prescription drugs; (accompanied by bill, House, No. 1205) of Bradley H. Jones, Jr., and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs; (accompanied by bill, House, No. 1206) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to contracts between the MassHealth program and pharmaceutical benefit managers; (accompanied by bill, House, No. 1215) of John J. Lawn, Jr., and others relative to pharmacy benefit managers; (accompanied by bill, House, No. 1246) of William M. Straus relative to drug prices paid by carriers; and (accompanied by bill, House, No. 1247) of Alyson M. Sullivan-Almeida, Michael J. Soter and David F. DeCoste relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth, reports the accompanying bill (Senate, No. 2492).
Every action
7 steps, oldest first, as the legislature records them.
- CommitteeReported from the committee on Health Care Financing · Joint Committee on Health Care Financing
- SenateNew draft of S732, S749, S767, S778, S783, S784, S797, H619, H1176, H1201, H1205, H1206, H1215, H1246 and H1247
- CommitteeBill reported favorably by committee and referred to the committee on Senate Ways and Means · Senate Committee on Ways and Means
- CommitteeCommittee recommended ought to pass with an amendment, substituting a new draft, see S2499 · Senate Committee on Ways and Means
- SenateOrder relative to subject matter adopted
- SenatePlaced in the Orders of the Day for Wednesday, November 15, 2023
- SenateRead second
Roll calls
1 recorded vote: 0 on the floor, 1 in committee. Each shows how every member voted.
Committee votes
| Date | Where | Question | Result |
|---|---|---|---|
| Nov 9, 2023 | Senate Committee on Ways and Means | Committee report: Favorable with Amendment (Ought to pass – by substitution of a New Draft) | 15–0 |
Sponsors
The 0 members who introduced it, joined by 38 cosponsors: 28 Democrats, 9 Republicans, 1 Independent.
- JC Joint Committee on Health Care Financing Sponsoring committee
All 38 cosponsors
- Angelo L. D'EmiliaR
- Bradley H. Jones, Jr.R
- Bruce E. TarrR
- Carmine Lawrence GentileD
- Carole A. FiolaD
- Christopher HendricksD
- Cindy F. FriedmanD
- Edward F. CoppingerD
- F. Jay BarrowsR
- Jack Patrick LewisD
- James B. EldridgeD
- Jason M. LewisD
- Joanne M. ComerfordD
- John J. Lawn, Jr.D
- Josh S. CutlerD
- Julian CyrD
- Kate HoganD
- Kimberly N. FergusonR
- Lindsay N. SabadosaD
- Marcus S. VaughnR
- Michael J. FinnD
- Michael O. MooreD
- Mindy DombD
- Natalie M. HigginsD
- Nicholas A. BoldygaR
- Patricia D. JehlenD
- Patrick M. O'ConnorR
- Paul R. FeeneyD
- Rebecca L. RauschD
- Rodney M. ElliottD
- Samantha MontañoD
- Smitty PignatelliD
- Steven OwensD
- Susan Williams GiffordR
- Susannah M. WhippsI
- Vanna HowardD
- William J. Driscoll, Jr.D
- William M. StrausD
From Massachusetts's official records (malegislature.gov/api), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.